AKT1 and neoplasm: Nevertheless, our data overall demonstrate that even in the context of wild-type PTEN function, the dual targeting of AKT and ErbB leads to greater anti-tumor responses in DU145 and DU145/Doc cells (Table 2, Figure 3, Figure S1).